Navigation Links
Google, Yahoo 'Personal Trainers' Strengthen Digital Delts, Partner With Saatchi & Saatchi Healthcare Communications Group Teams in Tech Circuit Training
Date:2/7/2008

es spanning 104 countries on five continents, the Groupe employs approximately 44,000 professionals.

The Groupe offers local and international clients a complete range of communication services, from advertising, through three autonomous global advertising networks, Leo Burnett, Publicis, Saatchi & Saatchi and two multi-hub networks, Fallon and 49%-owned Bartle Bogle Hegarty; to media consultancy and buying, through two worldwide networks, Starcom MediaVest Group and ZenithOptimedia; interactive and digital marketing led by Digitas; Specialized Agencies and Marketing Services (SAMS) offering healthcare communications, corporate and financial communications, public relations, CRM and direct marketing, event communications, sports marketing and multicultural communications. Web site: http://www.publicisgroupe.com


'/>"/>
SOURCE Saatchi & Saatchi Healthcare Communications Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Impact of electronic personal health record on hypertension under study
2. Personality Traits Dont Affect Breast Cancer Risk
3. Granholm Looks To Make Big Bucks for Personal Injury Lawyers, Says Michigan Chamber of Commerce
4. Health and Technology Leaders Tackle Challenge of Managing Consumers Identities in Web-Based Personal Health Tools
5. Your personality type influences how much self-control you have
6. Discovery opens door to personalized asthma therapy
7. Sense of personal control influences Latinas decisions about sexual debut
8. Preschoolers nightmares less prevalent, are trait-like and associated with personality
9. Personal Fitness Training Goes Online for 2008
10. Scientists identify brain abnormalities underlying key element of borderline personality disorder
11. Adult ADHD significantly impacts on social, financial and personal aspects of life
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 1Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 2Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 4Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 5Former Microsoft Healthcare Executive Joins iMedExchange 53828 1Former Microsoft Healthcare Executive Joins iMedExchange 53828 2Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 1Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 2Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 3